Editöre Mektup
BibTex RIS Kaynak Göster

Yıl 2021, Cilt: 3 Sayı: 1, 10 - 11, 23.04.2021

Halit Oğuz Ömer Yılmaz

Öz

Kaynakça

  • Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
  • Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
  • Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
  • Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
  • Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.

Increasing cases of Orbital Mucormycosis in recent years

Yıl 2021, Cilt: 3 Sayı: 1, 10 - 11, 23.04.2021

Halit Oğuz Ömer Yılmaz

Öz

Mucormycosis is a uncommon but aggressive and lethal fungal infection, which can rapidly spread especially in immunosuppressed patients. In recent years, there has been a serious increase in the number of orbital mucormycosis cases and publications. Mucormycosis prevalence in India is approximately 70 times more than the prevalence in developed countries. Diabetes mellitus, immunosuppression and trauma are major risk factors. Recently, COVİD-19 disease is common. COVID-19 infection and its treatment lead to immunosuppression, this has made patients vulnerable to secondary infections, including mucormycosis. Ophthalmologists should be aware of the possible vision threatening complications.

Anahtar Kelimeler

mucormycosis covid19 pandemic ocular infection

Kaynakça

  • Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
  • Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
  • Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
  • Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
  • Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.
Toplam 5 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göz Hastalıkları
Bölüm Letter to The Editor
Yazarlar

Halit Oğuz 0000-0002-0983-5878

Ömer Yılmaz 0000-0001-5571-3735

Yayımlanma Tarihi 23 Nisan 2021
Kabul Tarihi 8 Haziran 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 3 Sayı: 1

Kaynak Göster

APA Oğuz, H., & Yılmaz, Ö. (2021). Increasing cases of Orbital Mucormycosis in recent years. Clinical and Experimental Ocular Trauma and Infection, 3(1), 10-11.
AMA Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. Nisan 2021;3(1):10-11.
Chicago Oğuz, Halit, ve Ömer Yılmaz. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection 3, sy. 1 (Nisan 2021): 10-11.
EndNote Oğuz H, Yılmaz Ö (01 Nisan 2021) Increasing cases of Orbital Mucormycosis in recent years. Clinical and Experimental Ocular Trauma and Infection 3 1 10–11.
IEEE H. Oğuz ve Ö. Yılmaz, “Increasing cases of Orbital Mucormycosis in recent years”, CEOTI, c. 3, sy. 1, ss. 10–11, 2021.
ISNAD Oğuz, Halit - Yılmaz, Ömer. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection 3/1 (Nisan 2021), 10-11.
JAMA Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. 2021;3:10–11.
MLA Oğuz, Halit ve Ömer Yılmaz. “Increasing Cases of Orbital Mucormycosis in Recent Years”. Clinical and Experimental Ocular Trauma and Infection, c. 3, sy. 1, 2021, ss. 10-11.
Vancouver Oğuz H, Yılmaz Ö. Increasing cases of Orbital Mucormycosis in recent years. CEOTI. 2021;3(1):10-1.
 Kapak Resmi İndir

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(CC BY-NC-SA 4.0)